Stay updated on Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.

Latest updates to the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's Revision tag was updated from v3.6.5 to v3.6.6, indicating a minor backend revision.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, representing a minor update to the page's revision history. No changes to the study details or core content are indicated.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded NIH-required analyses for adverse events by sex and by race for mothers and infants, and updated timeframes (e.g., From birth through Week 50 postpartum) and measure descriptions to reflect these analyses.SummaryDifference1%

- Check44 days agoChange Detected- Page revision updated from v3.6.3 to v3.6.4, indicating a newer build of the page.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, indicating a newer version of the page or its documentation. This change does not alter the study content presented on the page.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page now indicates recruitment has ended and includes new user guidance sections for reading the study record and joining the study; header formatting for Interventions was adjusted and the page revision updated to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.